Autonomic nervous system state, calcium channel activity and gene polymorphisms of angiotensin-converting enzyme inhibitor and β2-adrenergic receptor in patients with complicated essential arterial hypertension
https://doi.org/10.38109/2225-1685-2011-1-38-45
Abstract
About the Authors
A. S. JumagulovaKyrgyzstan
A. G. Polupanov
Kyrgyzstan
T. A. Romanova
Kyrgyzstan
N. B. Cheskidova
Kyrgyzstan
References
1. JNC 7 Express. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung, and Blood Institute. National High Blood Pressure Education Program. NIH Publication No. 03-5233. May 2003.
2. Vakili B., Okin P., Devereux R. Prognostic implications of left ventricular hypertrophy. Am. Heart J. 2001; 141:334-341.
3. Koren M., Richard B., Devereux M. et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann. Intern. Med. 1991; 114:345-352.
4. Levy D., Garrison R., Savage D. et al. Prognostic implications of echocardiographically - determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 1990; 322:1561-1566.
5. World Health Organization, Regional Office for Europe. European health for all databases (HFA-DB), 2006.
6. Kalmyrzaev B., Aldashev A., Khalmatov M., Polupanov A., Jumagulova A., Mamanova L., Wilkins M., Town M. A Genome-Wide Scan for Premature Hypertension Supports Linkage to Chromosome 2 in a Large Kyrgyz Family. Hypertension 2006; 48(5): 908-913.
7. Zee R.Y., Ridker P.M. et.al. Prospective evaluation of the angiotensin-converting enzyme insertion/ deletion polymorphism and the risk of stroke. Circulation 1999; 99:340-343.
8. Squire I.B., Reid J.L. Interactions between reninangiotensin system and autonomic nervous system. In Robertson JLS. The Renin Angiotensin System. London: Gower, 1993.
9. Grien K.K., Murphy T.J., Alexander R.W. Molecular biology of the renin-angiotensin system. Circulation 1993; 87: 1816-1828.
10. Esler M. Sympathetic activity in experimental and human hypertension. In Mancia G edc. Handbook of hypertension 1997; 17:628-673.
11. Simpson P.S., Kariya K., Karns L.R. et al. Adrenergic hormones and control of cardiac myocyte growth. Mol. Cell. Biochem. 1991; 104:35-43.
12. Leineweber K. Beta-adrenergic receptor polymorphism in human cardiovascular disease. Ann. Med. 2004; 36:64-69.
13. Duner E. et al. Intracellular free calcium abnormalities in fibroblasts from no-insulin dependent diabetic patients with without arterial hypertension. Hypertension 1997; 29(4): 1007-13.
14. Орлов С.Н., Покудин Н.И., Постнов Ю.В. Внутриклеточная концентрация свободного кальция в тромбоцитах: особенности, выявляемые при спонтанной гипертензии. Кардиология 1984; 4:93-98.
15. Gruska S. et al. Prevalenceof increased intracellular signal transduction in immortalized lymphoblasts from patients with arterial hypertension and normotensive subjects. J of Hypertension 1997; 15(1): 29-33.
Review
For citations:
Jumagulova A.S., Polupanov A.G., Romanova T.A., Cheskidova N.B. Autonomic nervous system state, calcium channel activity and gene polymorphisms of angiotensin-converting enzyme inhibitor and β2-adrenergic receptor in patients with complicated essential arterial hypertension. Eurasian heart journal. 2011;(1):38-45. (In Russ.) https://doi.org/10.38109/2225-1685-2011-1-38-45